Skip to main content

Neuronetics, Inc.

STIM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001227636

In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Neuronetics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of STIM: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders67248−17
Shares17.5M2.12M10.6M−4.81M (−31.3%)
Value$31.5M$3.82M$8.05M−$19.7M (−70.9%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Neuronetics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to STIM in Q3 2024
InstitutionSharesValue% of portfolio
Kent Lake PR LLC2,077,848$1.58M0.63%
Masters Capital Management LLC1,200,000$911.8K0.18%
BlackRock, Inc.384,262$292.0K0.00%
Accurate Wealth Management, LLC99,170$88.3K0.02%
Landscape Capital Management, L.L.C.69,263$52.6K0.01%
BLB&B Advisors, LLC14,000$10.6K0.00%
Engineers Gate Manager LP13,454$10.2K0.00%
BNP Paribas Arbitrage, SA271$2060.00%

Sold out (25)

Institutions that held Neuronetics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (2)

Institutions that held Neuronetics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STIM in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Kent Lake Capital LLC1,738,102$3.13M
BlackRock Inc.381,694$687.0K